Peanuts can cause a severe life-threatening allergic reaction, which is referred to as peanut allergy. This type of allergy is one of the most common cause of food allergy, which occurs when immune system reacts to protein found in peanuts. Casual skin contact can trigger the allergy if the affected area then touches the eyes, nose or mouth. Some of the commonly occurring symptoms of the allergy include constriction of airways resulting in anaphylaxis, sudden and extreme drop in blood pressure, difficulty in breathing due to swelled throat, dizziness, lightheadedness, digestive problems, itching or tingling in or around the mouth and throat, runny nose, and unconsciousness. Age, past allergy to peanuts, other food allergies, family history, and atopic dermatitis are some of the risk factors of the peanut allergy.
According to the research findings, majority of the pipeline drug candidates are being developed to be administered through intravenous route. It has been observed that the intravenous route of medication is convenient and provides improved patient’s compliance. Administration of therapeutics through intravenous route has also shown promising results in clinical studies.
Companies are collaborating to expand their product portfolio and geographical footprint. For instance, in October 2017, Aimmune Therapeutics Inc. entered into a clinical collaboration with Regeneron and its strategic alliance collaborator Sanofi-aventis Groupe to study AR101 in combination with dupilumab for the treatment of patients with peanut allergy.
Peanut Allergy Therapeutics Pipeline Analysis
- By Phase
- By Molecule Type
- By Route of Administration
- By Company
Food sensitivity is one of the critical sorts of hypersensitivity.
Food hypersensitivities can be achieved by dairy creatures' milk, shellfish, eggs, and various sorts of food varieties, including peanuts.
Nonetheless, nut touchiness is very prevalent in the current circumstance, especially in kids.
The most dangerous of these responses is an intense fundamental response called hypersensitivity.
Nut hypersensitivity is treated with only some trial medications since nothing suitable has been identified for the treatment of nut hypersensitivity.
The worldwide Peanut Allergy Vaccine market is isolated based on Type as AR101, ASP0892, and Others.
